COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy

Veterinary and Comparative Oncology

Volumn 9, Issue 2, 2011, Pages 141-148

  Belshaw, Z ^a   Constantio Casas, F ^a   Brearley, M J ^a   Dunning, M D ^b   Holmes, M A ^a   Dobson, J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ANDERSON MOORES VETERINARY SPECIALISTS   (United Kingdom)

Author keywords

Canine; Carcinoma; COX 2 expression; Nasal; Prognosis

Indexed keywords

CYCLOOXYGENASE 2;

ADENOCARCINOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; CARCINOMA; DOG; DOG DISEASE; ENZYMOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MORTALITY; NOSE TUMOR; PAPILLARY CARCINOMA; PROGNOSIS; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ANIMALS; CARCINOMA; CARCINOMA, PAPILLARY; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; DOSE FRACTIONATION; FEMALE; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; NOSE NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

CANIS FAMILIARIS;

EID: 79955984018     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2010.00243.x     Document Type: Article

References (33)

1. Madewell BR, Priester WA, Gillette EL and Snyder SP. Neoplasms of the nasal passages and paranasal sinuses in domesticated animals as reported by 13 veterinary colleges. American Journal of Veterinary Research 1976; 37: 851-856.
2. Lana SE, Dernell WS, Lafferty MH, Withrow SJ and LaRue SM. Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors. Veterinary Radiology and Ultrasound 2004; 45: 577-581.
3. Rassnick KM, Goldkamp CE, Erb HN, Scrivani PV, Njaa BL, Gieger TL, Turek MM, McNiel EA, Proulx DR, Chun R, Mauldin GE, Phillips BS and Kristal O. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993-2003). Journal of the American Veterinary Medical Association 2006; 229: 401-406.
4. Adams WM, Kleiter MM, Thrall DE, Klauer JM, Forrest LJ, La Due TA and Havighurst TC. Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors. Veterinary Radiology and Ultrasound 2009; 50: 330-335.
5. Adams WA, Bjorling DE, McAnulty JF, Green EM, Forrest LJ and Vail DM. Outcome of accelerated radiotherapy alone or accelerated radiotherapy followed by surgical exenteration of the nasal cavity in dogs with intranasal neoplasia: 53 cases Journal of the American Veterinary Medical Association 2005; 227: 936-941.
6. Henry CJ, Brewer WG Jr, Tyler JW, Brawner WR, Henderson RA, Hankes GH and Royer N. Survival in dogs with nasal adenocarcinoma: 64 cases (1981-1995). Journal of Veterinary Internal Medicine 1998; 12: 436-439.
7. Gieger T, Rassnick K, Siegel S, Proulx D, Bergman P, Anderson C, LaDue T, Smith A, Northup N and Roberts R. Palliation of clinical signs in 48 dogs with nasal carcinomas treated with coarse-fraction radiation therapy. Journal of the American Animal Hospital Association 2008; 44: 116-123.
8. Vanherberghen M, Day MJ, Delvaux F, Gabriel A, Clercx C and Peeters D. An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats. Journal of Comparative Pathology 2009; 141: 17-26.
9. Shiomitsu K, Johnson CL, Malarkey DE, Pruitt AF and Thrall DE. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours. Veterinary and Comparative Oncology 2009; 7: 106-114.
10. Paciello O, Borzacchiello G, Varricchio E and Papparella S. Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in canine nasal carcinomas. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine 2007; 54: 406-410.
11. Millanta F, Citi S, Della Santa D, Porciani M and Poli A. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Research and Treatment 2006; 98: 115-120.
12. Pairet M and Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundamentals of Clinical Pharmacology 1996; 10: 1-17.
13. Soumaoro LT, Uetake H, Takagi Y, Lida S, Higuchi T, Yasuno M, Enomoto M and Sugihara K. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis. Diseases of the Colon and Rectum 2006; 49: 392-398.
14. Cho MH, Yoon JH, Jaegal YJ, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Lee MC, Park CS, Woo Juhng S and Min KW. Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma. Breast 2006; 15: 390-398.
15. Pyo H, Kim YB, Cho NH, Suh CO, Park TK, Yun YS and Kim GE. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy. International Journal of Radiation Oncology, Biology, Physics 2005; 62: 725-732.
16. Bhandari P, Bateman AC, Mehta RL, Stacey BS, Johnson P, Cree IA, Di Nicolantonio F and Patel P. Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus. BMC Cancer 2006; 6: 134-143.
17. Impellizeri JA and Esplin DG. Expression of cyclooxygenase-2 in canine nasal carcinomas. The Veterinary Journal 2008; 176: 408-410.
18. Borzacchiello G, Paciello O and Papparella S. Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas. Journal of Comparative Pathology 2004; 131: 70-76.
19. Kleiter M, Malarkey DE, Ruslander DE and Thrall DE. Expression of cyclooxygenase-2 in canine epithelial nasal tumors. Veterinary Radiology and Ultrasound 2004; 45: 255-260.
20. Hayes A, Scase T, Miller J, Murphy S, Sparkes A and Adams V. COX-1 and COX-2 expression in feline oral squamous cell carcinoma. Journal of Comparative Pathology 2006; 135: 93-99.
21. Rossmeisl JH Jr, Robertson JL, Zimmerman KL, Higgins MA and Geiger DA. Cyclooxygenase-2 (COX-2) expression in canine intracranial meningiomas. Veterinary and Comparative Oncology 2009; 7: 173-180.
22. Mellanby RJ, Stevenson RK, Herrtage ME, White RA and Dobson JM. Long-term outcome of 56 dogs with nasal tumours treated with four doses of radiation at intervals of seven days. Veterinary Record 2002; 151: 253-257.
23. Dungworth DL, Hauser B, Hahn FF, Wilson DW, Haenichen T and Harkemer JR. Histological classification of tumors of the respiratory system of domestic animals. WHO International Classification of Tumors of Domestic Animals 1999; 6: 16-21.
24. LaDue TA, Dodge R, Page RL, Price GS, Hauck ML and Thrall DE. Factors influencing survival after radiotherapy of nasal tumors in 130 dogs. Veterinary Radiology and Ultrasound 1999; 40: 312-317.
25. Menczer J, Schrieber L, Sukmanov O, Kravtsov V, Berger E, Golan A and Levy T. COX-2 expression in uterine carcinosarcoma. Acta Obstetrica Gynecologica Scandinavia 2010; 89: 120-125.
26. Menczer J, Schrieber L, Kravtsov V, Berger E, Golan A and Levy T. COX-2 expression in epithelial ovarian carcinoma and platin sensitivity. European Journal of Gynaecology and Obstetrics 2009; 30: 531-535.
27. Allread DC, Harvey JM, Berardo M and Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathology 1998; 11: 155-168.
28. Henriksen KL, Rasmussen BB, Lykkesfeldt EA, Moller S, Ejlertsen B and Mouridsen HT. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays. Journal of Clinical Pathology 2007; 60: 397-404.
29. Smith WL, Garavito RM and DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Journal of Biological Chemistry 1996; 271: 33157-33160.
30. Eibl G. The role of PPAR-gamma and its interaction with COX-2 in pancreatic cancer. PPAR Research 2008; 2008: 326915
31. Agthe P, Caine AR, Gear RNA, Dobson JM, Richardson K and Herrtage ME. Prognostic significance of specific magnetic resonance imaging features in canine nasal tumours treated by radiotherapy. Journal of Small Animal Practice 2009; 50: 641-648.
32. Queiroga FL, Pires I, Lobo L and Lopes CS. The role of COX-2 expression in the prognosis of dogs with malignant mammary tumours. Research in Veterinary Science 2010; 88: 441-445.
33. Wang D and DuBios RN. Eicosanoids and cancer. Nature Reviews Cancer 2010; 10: 181-193.